![Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: how to solve this problem? Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: how to solve this problem?](https://www.escardio.org/static-file/Escardio/Medias/councils/council-for-cardiology-practice/news/Figure%201.%20Decision%20tree%20for%20oral%20anticoagulation%20in%20patients%20with%20atrial%20fibrillation.jpg?mts=1592578501000.jpg)
Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: how to solve this problem?
![Predictive value of CHA2DS2-VASc scores regarding the risk of stroke and all-cause mortality in patients with atrial fibrillation (CONSORT compliant). - Abstract - Europe PMC Predictive value of CHA2DS2-VASc scores regarding the risk of stroke and all-cause mortality in patients with atrial fibrillation (CONSORT compliant). - Abstract - Europe PMC](https://europepmc.org/articles/PMC6708930/bin/medi-98-e16560-g001.jpg)
Predictive value of CHA2DS2-VASc scores regarding the risk of stroke and all-cause mortality in patients with atrial fibrillation (CONSORT compliant). - Abstract - Europe PMC
theartofcardiology - • New Flashcard • “CHADS-VASc Score for Atrial Fibrillation Stroke Risk” Remember to use this score whenever you're deciding if anticoagulate or not a patient with atrial fibrillation. The assessment
![The Impact of CHA2DS2-VASc and HAS-BLED Scores on Clinical Outcomes in the Amplatzer Amulet Study - ScienceDirect The Impact of CHA2DS2-VASc and HAS-BLED Scores on Clinical Outcomes in the Amplatzer Amulet Study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1936879820312875-gr7.jpg)
The Impact of CHA2DS2-VASc and HAS-BLED Scores on Clinical Outcomes in the Amplatzer Amulet Study - ScienceDirect
![Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2DS2-VASc Score for Thromboembolic Risk Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2DS2-VASc Score for Thromboembolic Risk](https://www.ahajournals.org/cms/asset/d0d191e0-987d-42cc-983f-d06e4fcdb336/e003476fig02.jpg)
Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2DS2-VASc Score for Thromboembolic Risk
![Table 2 from Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation. | Semantic Scholar Table 2 from Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1a84262bf2416f30f2c400e67d530b3957f84ba5/3-Table2-1.png)
Table 2 from Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation. | Semantic Scholar
![JCM | Free Full-Text | The Thromboembolic Predictability of CHA2DS2-VASc Scores Using Different Echocardiographic Criteria for Congestive Heart Failure in Korean Patients with Nonvalvular Atrial Fibrillation JCM | Free Full-Text | The Thromboembolic Predictability of CHA2DS2-VASc Scores Using Different Echocardiographic Criteria for Congestive Heart Failure in Korean Patients with Nonvalvular Atrial Fibrillation](https://pub.mdpi-res.com/jcm/jcm-11-00300/article_deploy/html/images/jcm-11-00300-ag.png?1641801872)
JCM | Free Full-Text | The Thromboembolic Predictability of CHA2DS2-VASc Scores Using Different Echocardiographic Criteria for Congestive Heart Failure in Korean Patients with Nonvalvular Atrial Fibrillation
![Stroke Risk Factors Beyond the CHA 2 DS 2 -VASc Score: Can We Improve Our Identification of “High Stroke Risk” Patients With Atrial Fibrillation? | Thoracic Key Stroke Risk Factors Beyond the CHA 2 DS 2 -VASc Score: Can We Improve Our Identification of “High Stroke Risk” Patients With Atrial Fibrillation? | Thoracic Key](https://i1.wp.com/thoracickey.com/wp-content/uploads/2016/11/gr1-476.jpg?fit=376%2C505&ssl=1)
Stroke Risk Factors Beyond the CHA 2 DS 2 -VASc Score: Can We Improve Our Identification of “High Stroke Risk” Patients With Atrial Fibrillation? | Thoracic Key
![CHADS2 and CHA2DS2-VASc Scores in the Prediction of Clinical Outcomes in Patients With Atrial Fibrillation After Catheter Ablation | Journal of the American College of Cardiology CHADS2 and CHA2DS2-VASc Scores in the Prediction of Clinical Outcomes in Patients With Atrial Fibrillation After Catheter Ablation | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/ec6596ac-956f-4c0e-927d-ad54c11258e3/gr5.jpg)
CHADS2 and CHA2DS2-VASc Scores in the Prediction of Clinical Outcomes in Patients With Atrial Fibrillation After Catheter Ablation | Journal of the American College of Cardiology
![Table 1 from Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation? | Semantic Scholar Table 1 from Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/63e7ef97ef5bd0f249c299f7ec378b723dd0ce17/3-Table1-1.png)
Table 1 from Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation? | Semantic Scholar
![Does CHA2DS2-VASc Score Select Patients Who Will Benefit Most From Anticoagulation? | Revista Española de Cardiología Does CHA2DS2-VASc Score Select Patients Who Will Benefit Most From Anticoagulation? | Revista Española de Cardiología](https://static.elsevier.es/multimedia/18855857/0000006700000005/v2_201404301330/S1885585714000875/v1_201404301330/en/main.assets/gr1.jpeg)
Does CHA2DS2-VASc Score Select Patients Who Will Benefit Most From Anticoagulation? | Revista Española de Cardiología
CorConsult Rx - Here is a summary of CHADS VASc score to evaluate a patient's risk of forming an embolism (leading to a stroke) secondary to their atrial fibrillation. If you answer
![Should Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex) Receive Oral Anticoagulation? - ScienceDirect Should Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex) Receive Oral Anticoagulation? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109714073914-gr2.jpg)